Study Reveals More than Half of COVID-19 Vaccinated Feel Sick a Year Later

Over half of COVID-19 vaccine recipients in a recent study were found to be suffering from some form of health complications one year after taking the shots.

Among vaccine recipients, 52.8 percent of individuals were found to have at least 1 PCVS a month after primary vaccination. At 12 months, 64.6 percent reported at least 1 PCVS. Though the quality of life rose at six months following vaccination, it subsequently fell at 12 months.

The overall prevalence of PCVS among individuals vaccinated with AstraZeneca was 65.59 percent compared to COVAXIN’s 59.4 percent.

Among individuals who took booster shots, over eight out of ten reported at least one PCVS, which is far higher than the five in ten people from the unvaccinated group who reported a similar syndrome.

The prevalence of PCVS “was similar to long-term COVID; it declined over time and increased following booster immunization. Contrary to PCVS prevalence, QoL rises with time and falls after booster doses,” the study concluded.

Related Stories

11/17/2023

11/16/2023

“There was a statistically significant difference in the prevalence of PCVS and QoL between booster dose recipients and no booster dose recipients.” The study was conducted between September 2021 and May 2023.

The authors of the study pointed out that research on the effects of immunization and its effects on people with long-term COVID have caused “debate as they gave rise to varying outcomes.”

The study was funded by the Indian Council of Medical Research. The two authors of the study, Yogendra Shrestha and Rajesh Venkataraman, are from the Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, India.

They reported “no financial or interpersonal conflicts” that may have affected the study results. The Epoch Times reached out to the authors for comment.

Post-Vaccine Health Issues

More new studies are giving further evidence linking COVID-19 shots with health complications.

Out of the 17,636 individuals, 17,192 of them had taken Pfizer’s COVID-19 shot, while the remaining 444 received Moderna jabs.

“Thrombosis was frequently reported with any mRNA vaccine, followed by stroke, myocarditis, myocardial infarction, pulmonary embolism, and arrhythmia,” it said.

Thrombosis was found to be common among those who had taken the Pfizer vaccine. Stroke was common among Moderna vaccine recipients. While Pfizer reported 228 deaths, the Moderna group saw 56 deaths.

“The time between the vaccination dosage and the first symptom onset averaged 5.6 and 4.8 days with the mRNA-1273 (Moderna) vaccine and BNT162b2 (Pfizer).”

“To have 284 well-described deaths as a result of cardiovascular and or thrombotic complications is a striking finding in the medical literature for products that are still on the market and promoted by public health agencies all over the world.”

At least half the participants also reported dizziness, burning sensations, tinnitus, headache, insomnia, palpitations, and myalgia (muscle pain and aches). Study participants reported a median of 22 symptoms.

Dr. Malone helped invent the mRNA technology used in the mRNA COVID-19 vaccines like the one from Pfizer. He revealed that the vaccine contains a DNA sequence called SV40 and that this information was not disclosed to at least a few regulators.

The presence of SV40 in the vaccine is a “proven genotoxicity risk,” he warned. Genotoxicity refers to the ability of harmful substances to damage the genetic information in cells.

“And by the way, these DNA fragments may also be shown to contribute to genetic anomalies in fetus[es], which is one of the most prominent causes of premature abortion,” he said.